Dehydroepiandrosterone	NN	dehydroepiandrosterone O TermTag
has	VBZ	have O TermTag
strong	JJ	strong O TermTag
antifibrotic	JJ	antifibrotic O TermTag
effects	NNS	effect O TermTag
and	CC	and O TermTag
is	VBZ	be O TermTag
decreased	VBN	decrease O TermTag
in	IN	in O TermTag
idiopathic	JJ	idiopathic O TermTag
pulmonary	JJ	pulmonary O TermTag
fibrosis	NN	fibrosis O TermTag
.	.	. . NUPOS

Idiopathic	JJ	idiopathic O TermTag
pulmonary	JJ	pulmonary O TermTag
fibrosis	NN	fibrosis O TermTag
(	(	( ( NUPOS
IPF	NN	IPF O TermTag
)	)	) ) NUPOS
is	VBZ	be O TermTag
an	DT	a O TermTag
ageing-related	JJ	ageing-related O TermTag
lung	NN	lung O TermTag
disorder	NN	disorder O TermTag
characterised	VBN	characterize O TermTag
by	IN	by O TermTag
expansion	NN	expansion O TermTag
of	IN	of O TermTag
the	DT	the O TermTag
myofibroblast	JJ	myofibroblast O TermTag
population	NN	population O TermTag
and	CC	and O TermTag
aberrant	JJ	aberrant O TermTag
lung	NN	lung O TermTag
remodelling	NN	remodelling O TermTag
.	.	. . NUPOS

Dehydroepiandrosterone	NN	dehydroepiandrosterone O TermTag
(	(	( ( NUPOS
DHEA	NN	DHEA O TermTag
)	)	) ) NUPOS
,	,	, , NUPOS
a	DT	a dt NUPOS
steroid	NN	steroid O TermTag
pro-hormone	NN	pro-hormone O TermTag
,	,	, , NUPOS
decreases	VBZ	decrease O TermTag
with	IN	with O TermTag
age	NN	age O TermTag
but	CC	but O TermTag
an	DT	a O TermTag
exaggerated	JJ	exaggerated O TermTag
decline	NN	decline O TermTag
has	VBZ	have O TermTag
been	VBN	be O TermTag
associated	VBN	associate O TermTag
with	IN	with O TermTag
chronic	JJ	chronic O TermTag
degenerative	JJ	degenerative O TermTag
diseases	NNS	disease O TermTag
.	.	. . NUPOS

We	PRP	we O TermTag
quantified	VBD	quantify O TermTag
the	DT	the O TermTag
plasma	NN	plasma O TermTag
levels	NNS	level O TermTag
of	IN	of O TermTag
DHEA	NN	DHEA O TermTag
and	CC	and O TermTag
its	PRP$	its O TermTag
sulfated	JJ	sulfated O TermTag
form	NN	form O TermTag
(	(	( ( NUPOS
DHEA-S	NN	DHEA-S O TermTag
)	)	) ) NUPOS
in	IN	in O TermTag
137	CD	137 O TermTag
IPF	NN	IPF O TermTag
patients	NNS	patient O TermTag
and	CC	and O TermTag
58	CD	58 O TermTag
controls	NNS	control O TermTag
and	CC	and O TermTag
examined	VBD	examine O TermTag
the	DT	the O TermTag
effects	NNS	effect O TermTag
of	IN	of O TermTag
DHEA	NN	DHEA O TermTag
on	IN	on O TermTag
human	JJ	human O TermTag
lung	NN	lung O TermTag
fibroblasts	NNS	fibroblast O TermTag
.	.	. . NUPOS

Plasma	NN	plasma O TermTag
DHEA/DHEA-S	NN	DHEA/DHEA-S O TermTag
was	VBD	be O TermTag
significantly	RB	significant O TermTag
decreased	VBN	decrease O TermTag
in	IN	in O TermTag
male	JJ	male O TermTag
IPF	NN	IPF O TermTag
patients	NNS	patient O TermTag
(	(	( ( NUPOS
median	NN	median O TermTag
(	(	( ( NUPOS
range	NN	range O TermTag
)	)	) ) NUPOS
DHEA	NN	DHEA O TermTag
:	:	: : NUPOS
4.4	CD	4.4 O TermTag
(	(	( ( NUPOS
0.2-29.2	CD	0.2-29.2 O TermTag
)	)	) ) NUPOS
versus	CC	versus O TermTag
6.7	CD	6.7 O TermTag
(	(	( ( NUPOS
2.1-15.2	CD	2.1-15.2 O TermTag
)	)	) ) NUPOS
ng	NN	ng O TermTag
mL	NN	ml O TermTag
(	(	( ( NUPOS
-1	CD	-1 O TermTag
)	)	) ) NUPOS
,	,	, , NUPOS
p	NN	p NN PennPOS
<	JJR	< JJR PennPOS
0.01	CD	0.01 O TermTag
;	:	; : NUPOS
DHEA-S	NN	DHEA-S O TermTag
:	:	: : NUPOS
47	CD	47 O TermTag
(	(	( ( NUPOS
15.0-211	CD	15.0-211 O TermTag
)	)	) ) NUPOS
versus	CC	versus O TermTag
85.2	CD	85.2 O TermTag
(	(	( ( NUPOS
37.6-247.0	CD	37.6-247.0 O TermTag
)	)	) ) NUPOS
g	NN	g NN PennPOS
dL	NN	dl O TermTag
(	(	( ( NUPOS
-1	CD	-1 O TermTag
)	)	) ) NUPOS
,	,	, , NUPOS
p	NN	p NN PennPOS
<	JJR	< JJR PennPOS
0.001	CD	0.001 O TermTag
)	)	) ) NUPOS
,	,	, , NUPOS
while	IN	while O TermTag
in	IN	in O TermTag
females	NNS	female O TermTag
only	RB	only O TermTag
DHEA-S	NN	DHEA-S O TermTag
was	VBD	be O TermTag
significantly	RB	significant O TermTag
decreased	VBN	decrease O TermTag
(	(	( ( NUPOS
32.6	CD	32.6 O TermTag
(	(	( ( NUPOS
15.0-303.0	CD	15.0-303.0 O TermTag
)	)	) ) NUPOS
versus	CC	versus O TermTag
68.3	CD	68.3 O TermTag
(	(	( ( NUPOS
16.4-171	CD	16.4-171 O TermTag
)	)	) ) NUPOS
g	NN	g NN PennPOS
dL	NN	dl O TermTag
(	(	( ( NUPOS
-1	CD	-1 O TermTag
)	)	) ) NUPOS
,	,	, , NUPOS
p	NN	p NN PennPOS
<	JJR	< JJR PennPOS
0.001	CD	0.001 O TermTag
)	)	) ) NUPOS
.	.	. . NUPOS

DHEA	NN	DHEA O TermTag
caused	VBD	cause O TermTag
a	DT	a dt NUPOS
decrease	NN	decrease O TermTag
in	IN	in O TermTag
fibroblast	NN	fibroblast O TermTag
proliferation	NN	proliferation O TermTag
and	CC	and O TermTag
an	DT	a O TermTag
approximately	RB	approximate O TermTag
two-fold	JJ	twofold O TermTag
increase	NN	increase O TermTag
in	IN	in O TermTag
fibroblast	NN	fibroblast O TermTag
apoptosis	NN	apoptosis O TermTag
,	,	, , NUPOS
probably	RB	probable O TermTag
through	IN	through O TermTag
the	DT	the O TermTag
intrinsic	JJ	intrinsic O TermTag
pathway	NN	pathway O TermTag
with	IN	with O TermTag
activation	NN	activation O TermTag
of	IN	of O TermTag
caspase-9	NN	caspase-9 O TermTag
.	.	. . NUPOS

This	DT	this O TermTag
effect	NN	effect O TermTag
was	VBD	be O TermTag
accompanied	VBN	accompany O TermTag
by	IN	by O TermTag
upregulation	NN	upregulation O TermTag
of	IN	of O TermTag
several	JJ	several O TermTag
pro-apoptotic	JJ	pro-apoptotic O TermTag
proteins	NNS	protein O TermTag
(	(	( ( NUPOS
Bax	NN	bax GENE TermTag
and	CC	and O TermTag
cyclin-dependent	JJ	cyclin-dependent O TermTag
kinase-inhibitor	NN	kinase-inhibitor O TermTag
CDNK1A	NN	CDNK1A O TermTag
)	)	) ) NUPOS
and	CC	and O TermTag
downregulation	NN	downregulation O TermTag
of	IN	of O TermTag
anti-apoptotic	JJ	anti-apoptotic O TermTag
proteins	NNS	protein O TermTag
,	,	, , NUPOS
such	JJ	such O TermTag
as	IN	as O TermTag
cellular	JJ	cellular O TermTag
inhibitor	NN	inhibitor O TermTag
of	IN	of O TermTag
apoptosis	NN	apoptosis O TermTag
(	(	( ( NUPOS
c-IAP	NN	c-IAP O TermTag
)	)	) ) NUPOS
1	CD	1 crd NUPOS
and	CC	and O TermTag
c-IAP2	NN	c-IAP2 O TermTag
.	.	. . NUPOS

DHEA	NN	DHEA O TermTag
also	RB	also O TermTag
caused	VBD	cause O TermTag
a	DT	a dt NUPOS
significant	JJ	significant O TermTag
decrease	NN	decrease O TermTag
of	IN	of O TermTag
transforming-growth-factor-b1-induced	JJ	transforming-growth-factor-b1-induced O TermTag
collagen	NN	collagen O TermTag
production	NN	production O TermTag
and	CC	and O TermTag
fibroblast	NN	fibroblast O TermTag
to	TO	to O TermTag
myofibroblast	NN	myofibroblast O TermTag
differentiation	NN	differentiation O TermTag
,	,	, , NUPOS
and	CC	and O TermTag
inhibited	VBD	inhibit O TermTag
platelet-derived	JJ	platelet-derived O TermTag
growth	NN	growth O TermTag
factor-induced	JJ	factor-induced O TermTag
fibroblast	NN	fibroblast O TermTag
migration	NN	migration O TermTag
.	.	. . NUPOS

These	DT	these O TermTag
findings	NNS	finding O TermTag
demonstrate	VBP	demonstrate O TermTag
a	DT	a dt NUPOS
disproportionate	JJ	disproportionate O TermTag
decrease	NN	decrease O TermTag
of	IN	of O TermTag
DHEA/DHEA-S	NN	DHEA/DHEA-S O TermTag
in	IN	in O TermTag
IPF	NN	IPF O TermTag
patients	NNS	patient O TermTag
and	CC	and O TermTag
indicate	VBP	indicate O TermTag
that	IN	that O TermTag
this	DT	this O TermTag
molecule	NN	molecule O TermTag
has	VBZ	have O TermTag
multiple	JJ	multiple O TermTag
antifibrotic	JJ	antifibrotic O TermTag
properties	NNS	property O TermTag
.	.	. . NUPOS

